跳至主要内容
临床试验/ISRCTN29932357
ISRCTN29932357已完成4 期

Metformin to prevent progression of sarcopenia and frailty for older people – a randomised controlled proof of concept trial

ewcastle upon Tyne Hospitals NHS Foundation Trust0 个研究点目标入组 72 人开始时间: 2021年1月21日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
72

研究概览

简要总结

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35851031/ (added 18/08/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged 65 years or over
  • 2. Low maximum handgrip strength (<16 kg for women, <27 kg for men)
  • 3. Walk speed <0.8 m/s on 4-m walk test

排除标准

  • 1. Diabetes mellitus (type 1 or type 2)
  • 2. eGFR <45 ml/min/1.73 m2 by MDRD4 or CKD-EPI equation
  • 3. History of diarrhoeal illness within the last 3 months (>48 h of Bristol stool chart grade 6 or 7 )
  • 4. Alcohol intake >21 units/week (women) or >35 units/week (men)
  • 5. Symptomatic chronic heart failure, diagnosed according to European Society of Cardiology guidelines (asymptomatic left ventricular systolic dysfunction will not be an exclusion criterion)
  • 6. Liver function tests (bilirubin, alanine aminotransferase or alkaline phosphatase) >3x upper limit of normal
  • 7. Oral steroid dose >7.5 mg prednisolone equivalent per day
  • 8. Unable to mobilise without human assistance
  • 9. Life expectancy of <3 months as adjudicated by the local investigator
  • 10. Unable to give written informed consent
  • 11. Previous intolerance of metformin or taking metformin for another condition
  • 12. Currently participating in, or participated within 30 days, another intervention study (observational studies and registries are permitted)

研究者

发起方
ewcastle upon Tyne Hospitals NHS Foundation Trust

相似试验